Recombinant Human LDH-A (N-6His)

Description

EnkiLife provides the Recombinant Human LDH-A (N-6His) protein,aslo know as L-Lactate Dehydrogenase A Chain,LDH-A,Cell Proliferation-Inducing Gene 19 Protein,LDH Muscle Subunit,LDH-M,Renal Carcinoma Antigen NY-REN-59,LDHA, which features high purity, high activity, and high stability. It can be applied in scientific research, biopharmaceuticals, and other fields.Purity:Greater than 95% as determined by reducing SDS-PAGE;Endotoxin Level:<1 EU/µg as determined by LAL test.;Construction:Recombinant Human L-Lactate Dehydrogenase A Chain is produced by our E.coli expression system and the target gene encoding Met1-Phe332 is expressed with a 6His tag at the N-terminus.Accession:P00338. Expression Host:E.coli.Species:Human.Predicted Molecular Mass:38.8 KDa. Background:L-Lactate Dehydrogenase A Chain (LDHA) is an enzyme that catalyzes the conversion of L-lactate and NAD+ to pyruvate and NADH in the final step of anaerobic glycolysis. LDHA contains an N-terminal coenzyme binding region, a central catalytic site, and at least nine utilized Lys acetylation and two Tyr phosphorylation sites. LDHA belongs to the lactate dehydrogenase family, expressed predominantly in muscle tissue. LDHA mutations have been linked to exertional myoglobinuria.